Tag: radiopharmaceuticals
Clarity and Nucleus RadioPharma scale up manufacturing for cancer treatment
Clarity Pharmaceuticals, a clinical-stage radiopharmaceutical company, has entered into a Master Services Agreement (MSA) and Clinical Manufacturing Agreement for the production of 67Cu-SAR-bisPSMA, a radiopharmaceutical treatment for prostate cancer.Â
Telix Pharmaceuticals announces manufacturing partnership with Japan’s JFE
Melbourne-based biopharmaceutical company Telix Pharmaceuticals has announced a manufacturing partnership with JFE Engineering Corporation, a Japanese company with extensive expertise in the installation of...
Australia set to become a major supplier of nuclear medicine
Australia broke ground on a new, A$168 million nuclear medicine facility, which will manufacture radiopharmaceuticals used to diagnose cancer and heart disease.
According to the...
Featured Article
Responding to manufacturing demand and performance signals
Australian manufacturers are navigating a challenging environment. Just as output had returned to growth, higher fuel and freight costs, rising input prices and global supply chain disruption renewed pressure on margins and cash flow.
